Literature DB >> 12830336

Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.

Jeffrey S Prince1, Melvin O Senac.   

Abstract

Ceftriaxone is a widely used third-generation cephalosporin. It is generally very safe, but complications of biliary pseudolithiasis and, rarely, nephrolithiasis have been reported in children. These complications generally resolve spontaneously with cessation of the ceftriaxone therapy; however, they may symptomatically mimic more serious clinical problems, such as cholecystitis. We report a case of both ceftriaxone-induced biliary pseudolithiasis and nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12830336     DOI: 10.1007/s00247-003-0963-0

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  9 in total

1.  Ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  O Herek; E Pakdemirli; N Koçer
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

2.  Ceftriaxone-associated nephrolithiasis.

Authors:  H Grasberger; B Otto; K Loeschke
Journal:  Ann Pharmacother       Date:  2000-09       Impact factor: 3.154

Review 3.  Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.

Authors:  R A de Moor; A C Egberts; C H Schröder
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

4.  Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.

Authors:  W M Kirejczyk; H M Crowe; I M Mackay; R Quintiliani; E B Cronin
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

5.  Gallstone pancreatitis caused by ceftriaxone.

Authors:  M C Maranan; S I Gerber; G G Miller
Journal:  Pediatr Infect Dis J       Date:  1998-07       Impact factor: 2.129

6.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

7.  Ceftriaxone choledocholithiasis.

Authors:  F M Robertson; T M Crombleholme; S E Barlow; M Verhave; D Brown
Journal:  Pediatrics       Date:  1996-07       Impact factor: 7.124

8.  Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.

Authors:  J P Bonnet; L Abid; A Dabhar; A Lévy; Y Soulier; S Blangy
Journal:  Eur J Pediatr Surg       Date:  2000-12       Impact factor: 2.191

9.  Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  A Palanduz; I Yalçin; E Tonguç; N Güler; U Oneş; N Salman; A Somer
Journal:  J Clin Ultrasound       Date:  2000-05       Impact factor: 0.910

  9 in total
  20 in total

1.  Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.

Authors:  Masoumeh Mohkam; Abdollah Karimi; Atoosa Gharib; Hamid Daneshmand; Alireza Khatami; Nozar Ghojevand; Mostafa Sharifian
Journal:  Pediatr Nephrol       Date:  2007-01-17       Impact factor: 3.714

2.  Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.

Authors:  Sendia Kim; Kathleen M Gura; Mark Puder
Journal:  Pediatr Surg Int       Date:  2006-02-17       Impact factor: 1.827

3.  A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.

Authors:  Naoki Kutuya; Yutaka Ozaki; Tadaharu Okazaki
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

4.  Ceftriaxone associated urolithiasis in a child with hypercalciuria.

Authors:  V J Lozanovski; Z Gucev; V J Avramoski; I Kirovski; P Makreski; V Tasic
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

Review 5.  Early-onset neonatal sepsis.

Authors:  Kari A Simonsen; Ann L Anderson-Berry; Shirley F Delair; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

6.  Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.

Authors:  Alper Otunctemur; Emin Ozbek; Emre Can Polat; Mustafa Cekmen; Murat Dursun; Suleyman Sami Cakir
Journal:  Urolithiasis       Date:  2013-12-06       Impact factor: 3.436

Review 7.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 8.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 9.  Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review.

Authors:  Yifan Zhang; Benxiang Ning; Huaijun Zhu; Xiaoming Cong; Leqing Zhou; Qiang Wang; Liming Zhang; Xizhao Sun
Journal:  Int Urol Nephrol       Date:  2016-04-28       Impact factor: 2.370

10.  Acute kidney injury caused by ceftriaxone-induced urolithiasis in children: a single-institutional experience in diagnosis, treatment and follow-up.

Authors:  Xiaowei Shen; Wang Liu; Xiaoliang Fang; Jianye Jia; Houwei Lin; Maosheng Xu; Hongquan Geng
Journal:  Int Urol Nephrol       Date:  2014-05-31       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.